Sapropterin Dipharma ইউরোপীয় ইউনিয়ন - চেক - EMA (European Medicines Agency)

sapropterin dipharma

dipharma arzneimittel gmbh - sapropterin-dihydrochloridu - fenylketonurie - jiné zažívací trakt a produkty metabolismu, - sapropterin dipharma is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment. sapropterin dipharma is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.

DABIGATRAN ETEXILÁT+PHARMA 150MG Tvrdá tobolka চেক প্রজাতন্ত্র - চেক - SUKL (Státní ústav pro kontrolu léčiv)

dabigatran etexilát+pharma 150mg tvrdá tobolka

+pharma arzneimittel gmbh, graz array - 17915 dabigatran-etexilÁt-mesilÁt - tvrdá tobolka - 150mg - dabigatran-etexilÁt